CLINICAL_TRIALS
trial_result
· 2015-03-10
Clinical Trial Update: A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma [Phase 3]
Summary
A Phase 3 trial evaluating palifermin for reducing oral mucositis in patients with multiple myeloma has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Swedish Orphan Biovitrum | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2015-03-10